The global Dry Powder Inhaler Market is expected to reach a market size of USD 52.43 Billion by 2027, and register a high CAGR during the forecast period, according to a new report by Reports and Data.

The prevalence of respiratory disorders including asthma and chronic obstructive pulmonary disease is on the rise, which is what is driving the market for respiratory Dry Powder Inhaler (COPD). Market participants are investing in the creation of cutting-edge portable inhalation devices, which will further the market's expansion.

Request Free Sample Copy @ https://www.reportsanddata.com/download-free-sample/3770

Further key findings from the report suggest

• Dry powder inhalers are preferred over metered-dose inhaler (MDI) as it is much easier to use and causes few irritants. After the ban on inhalers using chlorofluorocarbons (CFC), market players have entered dry powder segment to provide wide range of products to patients suffering from respiratory problems.
• Rising adoption of digitally operated Dry Powder Inhaler by market players to treat respiratory diseases and improve the efficacy of prescribed medicine is thereby driving growth of the segment.
• Chronic obstructive pulmonary disease (COPD) dominated the application segments in 2019 due to high number of active smokers globally and increase in geriatric population in many countries. Currently, there is no cure for the disease, but proper treatment can slow progression of the disease. Respiratory Dry Powder Inhaler help patients suffering from COPD to breathe easier.
• North America accounted for the largest revenue share in the respiratory Dry Powder Inhaler market in 2019. Robust presence of advanced research infrastructures in countries in the region and high adoption of smart inhalers is another factor supporting market growth.

Key Players covered in this report are

AstraZeneca, Cipla Ltd., Merck Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Medisol Lifescience Pvt. Ltd., Koninklijke Philips N.V., Novartis AG, Philips Healthcare, and 3M.

Product Type Outlook (Revenue, USD Billion; 2017-2027)

• Dry Powder Inhaler
• Metered Dose Inhaler
• Nebulizer
  • Compressed Air Nebulizer
  • Ultrasonic Nebulizer
  • Mesh Nebulizer

Mode of Operation Outlook (Revenue, USD Billion; 2017-2027)

• Digitally Operated Dry Powder Inhaler
• Manually Operated Dry Powder Inhaler

Application Outlook (Revenue, USD Billion; 2017-2027)

• Chronic Obstructive Pulmonary Disease
• Asthma
• Pulmonary Arterial Hypertension
• Others

Geographic Segment Covered in the Report:

The Respiratory Dry Powder Inhaler report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)

Major Points covered in this report are as below:

• The Respiratory Dry Powder Inhaler industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Respiratory Dry Powder Inhaler Market report provides key statistics on the market status of the Respiratory Dry Powder Inhaler manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3770

I appreciate you reading the report. Additionally take note that we provide report customization based on client needs. Please get in touch with us to learn more about the customisation option, and our staff will deliver a report that is suitable for your needs.

Get Explore Latest Research Report by Reports and Data:

https://www.einpresswire.com/article/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027

https://autism.einnews.com/pr_news/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027

https://braincancer.einnews.com/pr_news/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027

https://breastcancer.einnews.com/pr_news/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027

https://breastfeeding.einnews.com/pr_news/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027

https://dental.einnews.com/pr_news/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027

https://supplements.einnews.com/pr_news/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027

https://h1n1.einnews.com/pr_news/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027

https://h7n9birdflu.einnews.com/pr_news/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027

https://insuranceexchanges.einnews.com/pr_news/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027

https://health.einnews.com/pr_news/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027

https://healthreform.einnews.com/pr_news/601405210/imipenem-market-trend-growth-size-forecast-key-players-and-competitive-landscape-research-report-2027 

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com